Far From Certican: Novartis Hopes REMS Will Tip Balance For Kidney Transplant Drug

FDA's cardio-renal committee will weigh whether a communication-focused risk management plan can assuage concerns about renal toxicity and slow wound healing.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet